H2020Индивидуална стипендия2019–2021

4F4REJUVENGLIA · 4F-induced rejuvenation of glia into neural stem cells for brain repair

„Хоризонт 2020“ — Действия „Мария Склодовска-Кюри“

Период
2019-05-01 → 2021-11-28
Финансиране от ЕС
212 934 €
Участници
1
Схема
MSCA-IF

Линиите свързват координатора с партньорите.

Накратко на български

Глиалните клетки в мозъка се изследват за възможността да бъдат превърнати в нервни стволови клетки чрез частично препрограмиране. Това е важно, защото при невродегенеративни заболявания като болестта Алцхаймер мозъкът почти не може сам да възстановява загубените неврони.

Този кратък обзор е генериран от изкуствен интелект

Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.

Резултати накратко

4F-induced rejuvenation of glia into neural stem cells for brain repair

Human life expectancy has increased more than two-fold over the past two centuries, resulting in a dramatic increase in the elderly population. Advanced age is associated with physiological decline, which ultimately lead to an enhanced predisposition to diseases. Aging is the highest risk factor for neurodegenerative diseases. Remarkably, Alzheimer disease and other dementias are among the most common causes of death. The World Health Organization reported that up to 1 billion people, nearly one in six of the world’s population, suffer from neurological diseases, which make these disorders a growing burden for aged societies worldwide (1). Many of these neurological disorders have in common the malfunction of neurons, but most neurons are not replaced during normal life or pathological situations. The formation of neurons or neurogenesis is rare in postnatal life, and only occurs in two confined areas of the mammalian brain. Because adult neurogenesis is limited, the regenerative capacity of the brain is restrained and the possibilities of recovery from damage are almost absent. Current clinical interventions for neurological dysfunction are very limited, highlighting the need for strategies to palliate the loss of functional neurons occurring in these conditions. This project, 4F4REJUVENGLIA (short for: 4 Factors for rejuvenating glia)focuses on a novel approach to address regeneration in the nervous system, based on nuclear cell reprogramming technology, to generate new neurons in regions naturally devoid of neurogenesis. Current methods of reprogramming use direct conversion from glial cells to neurons by the expression of proneural factors I proposed an alternative approach, partial reprogramming, based in the short expression of the Yamanaka factors, to facilitate the conversion from glia to neuron through an intermediate progenitor state. We hypothesise that this “rewinding” to a neural progenitor-like state may rearrange the local environment and remodel it towards a stem cell niche that help instruct and integrate new neurons within the preexisting circuits. The project is guided by the objective of harnessing the potential offered by cell reprogramming technology to manipulate tissue regeneration and explore its applications to promote brain repair. The strategy is to use reprogramming to reinstall neurogenesis in brain areas, such as the cerebral cortex, which are naturally devoid of neurogenesis once embryogenesis is completed. The formation of new neurons aims to compensate for the degeneration of these cells occurring in pathophysiological conditions and to promote the regeneration of damaged brain areas.

Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз

Цел на проекта

Although the concept of adult neurogenesis has important implications for regenerative medicine, the formation of new functional neurons from progenitors during adult life is rare and occurs only in confined areas of the mammalian brain . Because adult neurogenesis is limited, the regenerative capacity of the brain is restrained and the possibilities of recovery from damage are almost absent. The WHO* reported that up to 1 billion people, nearly one in six of the world’s population, suffer from neurological disorders. Many of these disorders have the loss or malfunction of neurons in common. Alongside the rapid increase of life expectancy whereby it is estimated that a quarter of Europeans will be over 60 years of age by 2020, these types of disorders are becoming a growing burden for aging societies, in terms of both suffering and economic cost. In Europe, for example, the total cost of brain disorders was estimated at €386 billion in 2004 and increased to €798 billion in 2010.This project, 4F4REJUVENGLIA (short for: 4 factors for rejuvenating glia), focuses on a novel approach to engineer neurogenesis, based on nuclear cell reprogramming technology, to induce regeneration of damaged areas of the brain. The aim is to generate new neurons in regions naturally devoid of neurogenesis. The approach involves the overexpression of the Yamanaka factors directly in parenchymal glia, with the purpose of reprograming/rejuvenating these cells back in development in order to recover their stem cell potential lost during specification (Fig.1). We hypothesise that this “rewinding” to a neural progenitor-like state may rearrange the local environment and remodel it towards a stem cell niche that help instruct and integrate new neurons within the preexisting circuits.

Оригинален текст от CORDIS (на английски).

Участници

Връзки

Данни: CORDIS, © Европейски съюз